BSECompany UpdateMgmt Change29 Sept 2026
DR. AGARWAL'S HEALTH CARE LIMITED
DR. AGARWAL'S HEALTH CARE LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Dr. Agarwal's Health Care Limited has informed BSE about the completion of tenure of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change29 Sept 2026
DR. AGARWAL'S HEALTH CARE LIMITED
DR. AGARWAL'S HEALTH CARE LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Dr. Agarwal's Health Care Limited has informed BSE about the completion of tenure of a Non-Executive Independent Director.
BSECompany UpdateMgmt Change29 Sept 2026
DR. AGARWAL'S HEALTH CARE LIMITED
DR. AGARWAL'S HEALTH CARE LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Dr. Agarwal's Health Care Limited has informed BSE about the completion of tenure of a Non-Executive Independent Director.
BSECompany UpdateExpansion29 Sept 2026
Dr. Agarwals Health Care Ltd
Update on Step-down wholly owned subsidiary in Nigeria by Orbit Healthcare Services (Mauritius) Limited, a direct wholly owned subsidiary of the Company.
Dr. Agarwals Health Care Ltd has received an intimation from its step-down wholly owned subsidiary in Nigeria, confirming its acquisition of Orbit Healthcare Services Nigeria Ltd, making it a wholly owned subsidiary of its Mauritius-based subsidiary, Orbit Healthcare Services (Mauritius) Limited.
BSECompany UpdateMgmt Change29 Sept 2026
Dr. Agarwals Health Care Ltd
Completion of Second Term of 5 (Five) Consecutive Years by Mr. Sanjay Anand (DIN: 02501139), Independent Director of the Company
Dr. Agarwals Health Care Ltd announces the completion of Mr. Sanjay Anand's second term as an Independent Director, effective September 29, 2026. The Board of Directors expresses gratitude for his contributions and provides the revised constitution of the Committees of the Board of Directors.
BSEInsider Trading / SASTResults28 Sept 2026
Dr. Agarwals Health Care Ltd
Closure of Trading Window pursuant to Dr. Agarwals Health Care Limited - Code of Conduct for Prevention of Insider Trading
Dr. Agarwals Health Care Ltd has announced the closure of its trading window for all designated persons and their immediate relatives, effective September 30, 2026, due to the finalization and publication of unaudited financial results for the quarter and half year ending September 30, 2026.
BSEAGM/EGMMgmt Change21 Sept 2026
Dr. Agarwals Health Care Ltd
Voting Results and the Consolidated Scrutinizer''s Report of the 16th AGM of the Company, is submitted.
Dr. Agarwal's Health Care Ltd has announced the voting results of its 16th Annual General Meeting (AGM), where all seven resolutions proposed were approved by the requisite majority of shareholders. The company has also re-appointed Dr. Anosh Agarwal as a Whole-Time Director and Chief Operating Officer.
BSECompany Update29 Aug 2026
Dr. Agarwals Health Care Ltd
Newspaper Advertisement - Sixteenth Annual General Meeting of Dr. Agarwals Health Care Limited, Instructions for e-Voting and Other Related Information, is submitted.
Dr. Agarwals Health Care Ltd has published a newspaper advertisement for its 16th Annual General Meeting (AGM) to be held on September 21, 2026, through video conferencing. The notice is also available on the company's website.
BSEOthersResults28 Aug 2026
Dr. Agarwals Health Care Ltd
Annual Report of the Company for the Financial Year 2025-26, is submitted.
Dr. Agarwals Health Care Ltd has submitted its Annual Report for the Financial Year 2025-26, along with a notice convening the Sixteenth Annual General Meeting (AGM) to be held on September 21, 2026, through video conferencing.
BSEAGM/EGMResults28 Aug 2026
Dr. Agarwals Health Care Ltd
Notice convening the Sixteenth AGM of the Company on September 21, 2026, along with the Annual Report for the financial year 2025-26, is submitted.
Dr. Agarwals Health Care Ltd has announced the notice convening the Sixteenth Annual General Meeting (AGM) to be held on September 21, 2026, along with the Annual Report for the financial year 2025-26.
BSECompany Update▲ PositiveExpansion27 Aug 2026
Dr. Agarwals Health Care Ltd
Media Release - Launch of World''s First Pinhole Pupilloplasty (PPP) Centre by Dr. Agarwals Eye Hospital Limited, a subsidiary of the Company, is submitted
Dr. Agarwals Health Care Ltd's subsidiary, Dr. Agarwal's Eye Hospital Limited, has launched the World's First Pinhole Pupilloplasty (PPP) Centre at its flagship facility in Chennai, marking an important step in advancing access to innovative, tissue-preserving solutions for selected patients affected by complex corneal conditions.
BSECompany UpdateMgmt Change25 Aug 2026
Dr. Agarwals Health Care Ltd
Intimation of Schedule of Analyst / Investors Meet is submitted.
Dr. Agarwals Health Care Ltd has announced a schedule of analyst/investor meets on September 16-18, 2026, in Gurgaon and Mumbai, where company officials will participate in one-on-one meetings and conferences.
BSEInsider Trading / SASTPledge25 Aug 2026
Dr. Agarwals Health Care Ltd
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
Catalyst Trusteeship Ltd has created a pledge over 7,538,303 equity shares of Dr. Agarwal's Health Care Ltd, constituting 2.38% of the issued and paid-up share capital, as part of a facility agreement with Hyperion Investments Pte. Ltd.
BSEInsider Trading / SASTPledge14 Aug 2026
Dr. Agarwals Health Care Ltd
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for DB International Trust (Singapore) Ltd
Dr. Agarwals Health Care Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from DB International Trust (Singapore) Ltd, indicating a change in shareholding due to a sale/disposal of 24,160,000 equity shares by Hyperion Investments Pte. Ltd, a borrower under a facility agreement.
BSEInsider Trading / SASTPledge14 Aug 2026
Dr. Agarwals Health Care Ltd
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Claymore Investments (Mauritius) Pte Ltd
Claymore Investments (Mauritius) Pte. Ltd. has disclosed a sale of 1,59,00,000 shares of Dr. Agarwals Health Care Ltd, reducing their stake from 20.06% to 15.04%.
BSEInsider Trading / SASTPledge14 Aug 2026
Dr. Agarwals Health Care Ltd
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hyperion Investments Pte Ltd
Dr. Agarwals Health Care Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Hyperion Investments Pte. Ltd. regarding the sale of 24,160,000 equity shares of the company. The acquisition represents a 7.57% stake in the company.
BSEInsider Trading / SASTRegulatory14 Aug 2026
Dr. Agarwals Health Care Ltd
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Invesco Mutual Fund
Dr. Agarwals Health Care Ltd has received a disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Invesco Mutual Fund, indicating a potential change in control or significant stake acquisition.
BSEInsider Trading / SASTPledge14 Aug 2026
Dr. Agarwals Health Care Ltd
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
Catalyst Trusteeship Ltd has released an encumbrance over 31,698,303 shares of Dr. Agarwals Health Care Ltd, reducing the total shares encumbered to 41,495,685.
BSEInsider Trading / SASTRegulatory14 Aug 2026
Dr. Agarwals Health Care Ltd
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ICICI Prudential Mutual Fund
Dr. Agarwals Health Care Ltd has made a disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, indicating a potential change in control or substantial acquisition of shares.
BSECompany Update▲ PositiveResults7 Aug 2026
Dr. Agarwals Health Care Ltd
Transcript of the discussion held on the Unaudited Financial Results (Consolidated & Standalone) of the Company for the quarter ended June 30, 2026, at the analyst call held on August 04, ....
Dr. Agarwal's Healthcare Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with a total income of INR620 crores, a 24% year-on-year growth, and revenue from operations of INR614 crores, a 26% year-on-year growth. The company has also expanded its footprint by commissioning 18 new greenfield facilities, strengthening its reach and capacity.